LATHA SREE POLAVARAM MD NPI 1194934802

NPI Details

Latha Sree Polavaram, MD is a hematology and oncology internal medicine in Grand Rapids, MI with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Latha Sree Polavaram, MD NPI is 1194934802. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

145 MICHIGAN ST NE STE 3100
GRAND RAPIDS, MI
ZIP 49503-563
Phone: (616) 954-9800
Fax: (616) 954-2116

The NPI 1194934802 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Protein measurement, serum (HCPCS:84165)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Uric acid level, blood (HCPCS:84550)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood test, clotting time (HCPCS:85610)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Injection of drug or substance into vein (HCPCS:96374)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Unclassified drugs (HCPCS:J3490)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 5/21/2007 and was last updated on 3/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: